Christian Health Center | |
116 South Commonwealth Avenue, Corbin, Kentucky 40702 | |
(606) 258-2500 | |
Name | Christian Health Center |
---|---|
Location | 116 South Commonwealth Avenue, Corbin, Kentucky |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 104 |
Occupancy Rate | 77.12% |
Medicare ID (CCN) | 185232 |
Legal Business Name | Christian Care Communities, Inc. |
Ownership Type | Non Profit - Church Related |
NPI Number | 1255478210 |
Organization Name | CHRISTIAN CARE COMMUNITIES, INC. |
Doing Business As | CHRISTIAN HEALTH CENTER CORBIN |
Address | 116 S Commonwealth Ave, Corbin, KY 40701 |
Phone Number | 606-258-2500 |
News Archive
SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.
Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.
Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.
Royal Philips (NYSE: PHG, AEX: PHIA) today commented on a recent report of Cancer Research UK (CRUK), which indicates that innovations, such as digital pathology, image measurement and digital collaboration are recommended to avert major gaps in UK pathology services in the near future.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.
Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.
Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.
Royal Philips (NYSE: PHG, AEX: PHIA) today commented on a recent report of Cancer Research UK (CRUK), which indicates that innovations, such as digital pathology, image measurement and digital collaboration are recommended to avert major gaps in UK pathology services in the near future.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 18.71 | 14.46 |
Percentage of long-stay residents who lose too much weight | 12.18 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.98 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.9 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.62 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.98 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.46 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 13.4 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.48 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.85 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 35.37 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 30.65 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.76 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 67.95 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 94.44 | 82.93 |
News Archive
SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.
Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.
Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.
Royal Philips (NYSE: PHG, AEX: PHIA) today commented on a recent report of Cancer Research UK (CRUK), which indicates that innovations, such as digital pathology, image measurement and digital collaboration are recommended to avert major gaps in UK pathology services in the near future.
› Verified 6 days ago
Hillcrest Health And Rehabilitation Center Location: 1245 American Greeting Road, Corbin, Kentucky 40702 Phone: (606) 528-8917 | |
Christian Health Center Location: 116 South Commonwealth Avenue, Corbin, Kentucky 40702 Phone: (606) 258-2500 | |
Corbin Health And Rehabilitation Center Location: 270 Bacon Creek Road, Corbin, Kentucky 40702 Phone: (606) 528-8822 | |